Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.
van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, Erdmann JI, Gilbo N, de Haas RJ, Heaton N, van Hoek B, Huurman VAL, Jochmans I, van Leeuwen OB, de Meijer VE, Monbaliu D, Polak WG, Slangen JJG, Troisi RI, Vanlander A, de Jonge J, Porte RJ; DHOPE-DCD Trial Investigators. van Rijn R, et al. Among authors: de meijer ve, de jonge j, de vries y, de haas rj. N Engl J Med. 2021 Apr 15;384(15):1391-1401. doi: 10.1056/NEJMoa2031532. Epub 2021 Feb 24. N Engl J Med. 2021. PMID: 33626248 Clinical Trial.
Development of a set of patient reported outcome measures for patients with benign liver tumours and cysts: patient focus groups and systematic review.
Furumaya A, Nooijen LE, Haring MPD, van Oers HA, van Beneden M, van Rosmalen BV, Takkenberg RB, Kazemier G, Besselink MG, de Meijer VE, Erdmann JI; Dutch Benign Liver Tumor Group. Furumaya A, et al. Among authors: de meijer ve. J Patient Rep Outcomes. 2022 Dec 9;6(1):124. doi: 10.1186/s41687-022-00531-1. J Patient Rep Outcomes. 2022. PMID: 36484883 Free PMC article.
Prolonged hypothermic machine perfusion enables daytime liver transplantation - an IDEAL stage 2 prospective clinical trial.
Brüggenwirth IMA, Lantinga VA, Lascaris B, Thorne AM, Meerdink M, de Kleine RH, Blokzijl H, van den Berg AP, Reyntjens KMEM, Lisman T, Porte RJ, de Meijer VE; DHOPE-PRO Trial Investigators. Brüggenwirth IMA, et al. Among authors: de meijer ve, de kleine rh. EClinicalMedicine. 2024 Jan 5;68:102411. doi: 10.1016/j.eclinm.2023.102411. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38235423 Free PMC article.
Sleep quality, fatigue, societal participation and health-related quality of life in kidney transplant recipients: a cross-sectional and longitudinal cohort study.
Knobbe TJ, Kremer D, Eisenga MF, van Londen M, Annema C, Bültmann U, Kema IP, Navis GJ, Berger SP, Bakker SJL; TransplantLines Investigators. Knobbe TJ, et al. Nephrol Dial Transplant. 2023 Dec 20;39(1):74-83. doi: 10.1093/ndt/gfad148. Nephrol Dial Transplant. 2023. PMID: 37418245 Free PMC article.
Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients.
Kremer D, Knobbe TJ, Vinke JSJ, Groothof D, Post A, Annema C, Abrahams AC, van Jaarsveld BC, de Borst MH, Berger SP; TransplantLines Investigators; Bakker SJL, Eisenga MF. Kremer D, et al. Am J Transplant. 2024 Mar 15:S1600-6135(24)00213-2. doi: 10.1016/j.ajt.2024.03.017. Online ahead of print. Am J Transplant. 2024. PMID: 38493925 Free article.
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial.
Mackay TM, Latenstein AEJ, Augustinus S, van der Geest LG, Bogte A, Bonsing BA, Cirkel GA, Hol L, Busch OR, den Dulk M, van Driel LMJW, Festen S, de Groot DA, de Groot JB, Groot Koerkamp B, Haj Mohammad N, Haver JT, van der Harst E, de Hingh IH, Homs MYV, Los M, Luelmo SAC, de Meijer VE, Mekenkamp L, Molenaar IQ, Patijn GA, Quispel R, Römkens TEH, van Santvoort HC, Stommel MWJ, Venneman NG, Verdonk RC, van Vilsteren FGI, de Vos-Geelen J, van Werkhoven CH, van Hooft JE, van Eijck CHJ, Wilmink JW, van Laarhoven HWM, Besselink MG; Dutch Pancreatic Cancer Group. Mackay TM, et al. Among authors: de meijer ve. JAMA Surg. 2024 Apr 1;159(4):429-437. doi: 10.1001/jamasurg.2023.7872. JAMA Surg. 2024. PMID: 38353966 Free PMC article. Clinical Trial.
Pancreatectomy with arterial resection for periampullary cancer: outcomes after planned or unplanned events in a nationwide, multicentre cohort.
Stoop TF, Mackay TM, Brada LJH, van der Harst E, Daams F, Land FRV', Kazemier G, Patijn GA, van Santvoort HC, de Hingh IH, Bosscha K, Seelen LWF, Nijkamp MW, Stommel MWJ, Liem MSL, Busch OR, Coene PLO, van Dam RM, de Wilde RF, Mieog JSD, Quintus Molenaar I, Besselink MG, van Eijck CHJ; Dutch Pancreatic Cancer Group. Stoop TF, et al. Br J Surg. 2023 May 16;110(6):638-642. doi: 10.1093/bjs/znac353. Br J Surg. 2023. PMID: 36308339 Free PMC article. No abstract available.
Surgical Outcome After Pancreatoduodenectomy for Duodenal Adenocarcinoma Compared with Other Periampullary Cancers: A Nationwide Audit Study.
de Bakker JK, Suurmeijer JA, Toennaer JGJ, Bonsing BA, Busch OR, van Eijck CH, de Hingh IH, de Meijer VE, Molenaar IQ, van Santvoort HC, Stommel MW, Festen S, van der Harst E, Patijn G, Lips DJ, Den Dulk M, Bosscha K, Besselink MG, Kazemier G; Dutch Pancreatic Cancer Group. de Bakker JK, et al. Among authors: de meijer ve, de hingh ih. Ann Surg Oncol. 2023 Apr;30(4):2448-2455. doi: 10.1245/s10434-022-12701-y. Epub 2022 Dec 19. Ann Surg Oncol. 2023. PMID: 36536196 Free PMC article.
Nationwide use and Outcome of Minimally Invasive Distal Pancreatectomy in IDEAL Stage IV following a Training Program and Randomized Trial.
Korrel M, van Hilst J, Bosscha K, Busch ORC, Daams F, van Dam R, van Eijck CHJ, Festen S, Groot Koerkamp B, van der Harst E, Lips DJ, Luyer MD, de Meijer VE, Mieog JSD, Molenaar IQ, Patijn GA, van Santvoort HC, van der Schelling GP, Stommel MWJ, Besselink MG; Dutch Pancreatic Cancer Group. Korrel M, et al. Among authors: de meijer ve. Ann Surg. 2024 Feb 1;279(2):323-330. doi: 10.1097/SLA.0000000000005900. Epub 2023 May 4. Ann Surg. 2024. PMID: 37139822 Clinical Trial.
The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial.
van Dongen JC, Versteijne E, Bonsing BA, Mieog JSD, de Hingh IHJT, Festen S, Patijn GA, van Dam R, van der Harst E, Wijsman JH, Bosscha K, van der Kolk M, de Meijer VE, Liem MSL, Busch OR, Besselink MGH, van Tienhoven G, Groot Koerkamp B, van Eijck CHJ, Suker M; Dutch Pancreatic Cancer Group. van Dongen JC, et al. Among authors: de meijer ve, de hingh ihjt. Eur J Surg Oncol. 2023 Apr;49(4):811-817. doi: 10.1016/j.ejso.2022.12.011. Epub 2022 Dec 26. Eur J Surg Oncol. 2023. PMID: 36585300 Clinical Trial.
211 results